Allan, why are you doing this?
I've been posting on the Internet since the old Prodigy "Hypotheticals" thread, circa 1990. While it's ego satisfying to publish one's thoughts, I don't like to argue with people, especially strangers on the Internet. So this way I get the best of both worlds, publishing, but without accountability.
Is there a regular schedule for your blog?
Yes, whenever I feel like it.
Are the stocks you mention worth buying?
I thought so at the time. But if you're thinking about trading them, remember, I already bought in and usually at much lower prices. In fact, I might be selling out soon after mentioning a stock, or, as in the case of ELAB, trading in and out of a partial position and holding onto a partial position for an extended time.
Say what?
I'm trading full time and what I post here is but a small part of my trading activities. I think one of my purposes is to show that it can be done, to inspire others who may want to try full time trading as a vocation. Somewhere along the line, enough of this may make enough sense to you to give it a try, maybe not exactly the way I do it, but along your own path. Like I said, it can be done.
Buying anyting today?
PTSX, CLZR and CD.
4 comments:
Hi, Allan, to add to your blog: we just got an insider buy signal for cris (a biotech) which I think is still buyable since I bought some at 4.48. Vicl isn't working out so well for me, you can buy it now much cheaper. Don't bother responding.
No bother at all, Ilene. CRIS was a Director buying $248K worth of stock. VICL was the CEO, but he only bought $4K worth of stock, which he seems to do on a regular monthly schedule. So it's not surprising that CRIS popped, VICL didn't. Nonetheless, these Biotechs seem to act well if enought stock is involved and/or there are multiple officers/directors purchasing shares in the open market. Keep them coming, I want a 42 inch Sony LCD HD television ASAP.
"No bother at all,"
I was afraid if I didn't say "don't bother" you would. But seriously, I was bored re. buying vicl. Thanks. - Ilene
p.s. another biotech with a few small insider buys lately is nexm, which I'm just holding on to as the buys don't move it enough for day-trading, too small probably.
Post a Comment